Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems.
about
Tobacco Use Cessation and Prevention - A ReviewNicotine-mediated signals modulate cell death and survival of T lymphocytes.Pharmacological intervention of nicotine dependence.Using nicotine replacement therapy in treating nicotine addiction in adolescents.Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers.Treatment of tobacco dependence: integrating recent progress into practice.Evaluation of a novel nicotine inhaler device: part 2--effect on craving and smoking urges.APOE E4 Carriers show prospective memory enhancement under nicotine, and evidence for specialisation within medial BA10.Smoking cessation pharmacotherapy.Treating tobacco dependence in a medical setting.A preliminary study on the effect of combined nicotine replacement therapy on alcohol responses and alcohol self-administration.An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.Smoking cessation. 1: An overview of research.Tobacco smoking and nicotine dependence: biological basis for pharmacotherapy from nicotine to treatments that prevent relapse.Relations between toxicity and altered tissue distribution and urinary excretion of nicotine, cotinine, and hydroxycotinine after chronic oral administration of nicotine in rats.Smokeless nicotinergic stimulation of vasopressin secretion in patients with persisting nocturnal enuresis and controls.Nicotine effects on attentional reorienting in mid-age adults, and interactions with apolipoprotein E status.Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial.
P2860
Q26738823-386D2F6C-5842-4CAD-A125-5E3D5B15A184Q33620835-5068C629-5153-465B-B6E3-847B5D9EF725Q34401794-D3EE768E-E46F-49C4-8700-A4213F85E73DQ34555745-4F03EE11-2200-419B-862E-A78A2285EDADQ34660846-8BC5E93D-8053-46EC-AFE2-5C9312910A99Q34715360-1996C033-4894-4B54-8B80-88C867ED8F6EQ34803630-8FB6CCB4-119C-4E55-B337-A0703DEF05C5Q36610058-96F61DAA-BE4A-4D69-BA30-F51699C232B7Q37505737-E12D4ABD-F5CC-4695-AA16-F726A66D150DQ37520911-6E3EA88F-C666-403A-ABAD-401B0B10D57BQ37602654-A1913790-6990-486E-9053-12B48573B554Q39248772-9E5434AD-D523-478A-BF4F-0100C858A496Q41513562-713FA421-598E-44A1-A8CB-282814549EC4Q41741745-1F0CF58A-EC10-4A3B-B396-6458CA93EB37Q43122195-EBEFF4A0-475B-4A2D-88C1-6B5823C675A2Q43644294-BEAB8E1B-DD8D-4FD9-892C-848D00B45BB9Q46633828-BE0BE58A-3343-4A9E-9E0A-1DDE616B590FQ52297853-7FFA62B4-A18E-4BE4-A4C0-48703AC16F37
P2860
Clinical pharmacokinetics of nasal nicotine delivery. A review and comparison to other nicotine systems.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Clinical pharmacokinetics of n ...... son to other nicotine systems.
@en
type
label
Clinical pharmacokinetics of n ...... son to other nicotine systems.
@en
prefLabel
Clinical pharmacokinetics of n ...... son to other nicotine systems.
@en
P2093
P1476
Clinical pharmacokinetics of n ...... son to other nicotine systems.
@en
P2093
K O Fagerström
N G Schneider
R E Olmstead
P356
10.2165/00003088-199631010-00005
P577
1996-07-01T00:00:00Z
P5875
P6179
1047612675